BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26466909)

  • 1. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
    Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
    Yuksel A; Bildik G; Senbabaoglu F; Akin N; Arvas M; Unal F; Kilic Y; Karanfil I; Eryılmaz B; Yilmaz P; Ozkanbaş C; Taskiran C; Aksoy S; Guzel Y; Balaban B; Ince U; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2926-35. PubMed ID: 26466914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
    Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
    Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women.
    Su HI; Maas K; Sluss PM; Chang RJ; Hall JE; Joffe H
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1961-6. PubMed ID: 24081742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.
    Kashi O; Roness H; Spector I; Derech-Haim S; Meirow D
    Hum Reprod; 2023 Jun; 38(6):1086-1098. PubMed ID: 37015102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells.
    Billig H; Furuta I; Hsueh AJ
    Endocrinology; 1994 Jan; 134(1):245-52. PubMed ID: 8275940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
    Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
    Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
    Ozcelik B; Turkyilmaz C; Ozgun MT; Serin IS; Batukan C; Ozdamar S; Ozturk A
    Fertil Steril; 2010 Mar; 93(5):1609-14. PubMed ID: 19339002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.
    Horicks F; Van Den Steen G; Houben S; Englert Y; Demeestere I
    PLoS One; 2015; 10(9):e0137164. PubMed ID: 26325271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
    Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
    Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
    Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
    Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
    Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
    Imai A; Sugiyama M; Furui T; Tamaya T; Ohno T
    Gynecol Obstet Invest; 2007; 63(2):102-6. PubMed ID: 17028438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
    Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
    Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.
    Huang Y; Huang X; Huang X; Lin S; Luo S; Gu D; Weng X; Xu X
    Hum Reprod; 2023 Jun; 38(6):1099-1110. PubMed ID: 37075316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.